Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.06 USD | +1.18% | -4.03% | -10.55% |
05-10 | Wedbush Trims Xenon Pharmaceuticals' Price Target to $50 From $51, Maintains Outperform Rating | MT |
05-09 | Xenon Pharmaceuticals Q1 Net Loss Narrows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.55% | 3.06B | |
+7.63% | 111B | |
+11.19% | 106B | |
-12.34% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-9.05% | 16.81B | |
+38.39% | 12.54B | |
-24.53% | 8.09B |
- Stock Market
- Equities
- XENE Stock
- News Xenon Pharmaceuticals Inc.
- Baird Initiates Xenon Pharmaceuticals With Outperform Rating, Price Target is $63